Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

Auris Medical completes enrollment in AM-111 trial

April 24, 2012

Study reveals new therapeutic use for phosphodiesterase 5 inhibitors

Feb. 24, 2012

Pergamum begins phase II DPK-060 trial in outer ear infections

Jan. 17, 2012

JNK inhibitor prevents hearing loss due to transient cochlear ischemia in preclinical study

Jan. 12, 2012

Phage Pharmaceuticals submits IND for first-in-class therapeutic

Dec. 27, 2011

Second milestone reached in GenVec/Novartis collaboration

Dec. 7, 2011

Peptide P-13 ameliorates experimental otitis media

July 14, 2011

Sanofi and Audion Therapeutics to develop treatments for hearing loss

June 17, 2011

Sound Pharmaceuticals begins trial of SPI-1005 for hearing loss induced by loud music

June 8, 2011

Otonomy reports encouraging phase Ib data on OTO-104 in Meniere's disease

May 2, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...